Renhe Pharmacy

Renhe Pharmacy Co., Ltd. is a listed company on the Shenzhen Stock Exchange, with the stock code: 000650. The predecessor of the company was Jiujiang Chemical Fiber Co., Ltd., which was approved by the People's Government of Jiangxi Province in 1996. On November 18, 1996, it was approved by the China Securities Regulatory Commission (CSRC) Document No. 318 (1996), and officially listed on the Shenzhen Stock Exchange. In 2006, the company implemented a major asset restructuring, divesting its original chemical fiber-related assets while injecting pharmaceutical assets. Through multiple rights issues, capital increases, and private placements, the company has become a modern pharmaceutical production and operation enterprise with several subsidiaries, including Jiangxi Renhe Pharmacy Co., Ltd., Jiangxi Renhe Zhongfang Pharmaceutical Co., Ltd., Jiangxi Renhe Yudu Pharmaceutical Co., Ltd., Jiangxi Heli Pharmaceutical Co., Ltd., Jiangxi Kangmei Pharmaceutical and Health Products Co., Ltd., Jiangxi Yudu Renhe Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., Jiangxi Shining Pharmaceutical Co., Ltd., Jiangxi Ji'an Sanli Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Plastic Products Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., and Jiangxi Yudu Zhangshu Pharmaceutical Co., Ltd. The company’s main business includes the production and sales of Chinese and Western medicines, active pharmaceutical ingredients, and health-related products, including oral solid dosage forms, oral liquid dosage forms, large-volume injections, small-volume injections, external washing solutions, liniments, suppositories, ointments, and other pharmaceutical dosage forms as well as health-related products. The company's main products include Renhe Keli, Youkadan series, Fuyanjie series, Dahuo Luo capsules, Shining eye drops, Qinghuo capsules, Zhengwei capsules, etc.